Disseminated Herpes Zoster in immunocompetent host: A rare case report and review of the literature

Authors

  • Supitcha Kamolratanakul Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University
  • Jittima Dhitavat Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University

Keywords:

elderly, herpes zoster, immunocompetent, disseminated

Abstract

Disseminated cutaneous herpes zoster is uncommon in immunocompetent. Cutaneous dissemination 10-40% is occurring in immunosuppression, especially due to cell-mediated immunity (CMI) deficiency. Varicella zoster virus-specific CMI is required to halt the virus reactivation. Age-related decline of VZV CMI seems to be one of the most important risk factor for VZV reactivation and subsequent herpes zoster. Nevertheless disseminated herpes zoster in the elderly patient who has no immunosuppressive condition is uncommon. We report a case of elderly man with no apparent immunosuppressive condition presented with vesicular rash on T11 dermatome before generalized spreading of vesicular eruption in 3 days. The patient was treated successfully with intravenous acyclovir.

References

1. McCrary ML, Severson J, Tyring SK. Varicella zoster virus. Journal of the American Academy of Dermatology 1999; 41: 1-14; quiz 15-6.

2. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996; 9: 361-81.

3. Burdett C, Mendoza N, Arora A, et al. A rare case of disseminated shingles in an immunocompetent patient following a 7-day treatment with oral valacyclovir. J Clin Virol 2008; 43: 233-5.

4. Capron J, Steichen O. Disseminated zoster in an elderly patient. Infection 2009; 37: 179-80.

5. Chyen LH, Wee CM. Disseminated cutaneous zoster can occur in healthy individuals: A Case Series. Singapore Fam Physician 2011;37:51-5.

6. Gomez E, Chernev I. Disseminated cutaneous herpes zoster in an immunocompetent elderly patient. Infect Dis Rep 2014; 6: 5513.

7. Gupta S, Jain A, Gardiner C, Tyring SK. A rare case of disseminated cutaneous zoster in an immunocompetent patient. BMC Fam Pract 2005; 6: 50.

8. Merselis JG Jr, Kaye D, Hook EW. Disseminated herpes zoster: A report of 17 cases. Arch Intern Med 1964; 113: 679-86.

9. Moriuchi H, Moriuchi M, Sun CC, Trucksis M. Disseminated cutaneous zoster and aseptic meningitis in a previously healthy patient. J Infect 1997; 35: 183-5.

10. O’Toole EA, Mooney EE, Walsh JB, Sweeney EC, Barnes L. Disseminated herpes zoster in the elderly. Ir J Med Sci 1997; 166: 141-2.

11. Petrun B, Williams V, Brice S. Disseminated varicellazoster virus in an immunocompetent adult. Dermatol Online J 2015;21.

12. Sun ZH, Guo YY, Li M, Yao ZR. Disseminated herpes zoster in immunocompetent patients not due to varicella-zoster virus gene mutation. Chin Med J (Engl) 2013; 126: 3193.

13. Arvin A. Aging, Immunity, and the varicella–zoster Virus. N Engl J Med 2005; 352: 2266-7.

14. Arvin AM. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis 2008; 197: S58-60.

15. Shah S, Singaraju S, Einstein A, Sharma A. Herpes zoster: A clinicocytopathological insight. J Oral Maxillofac Pathol 2016; 20: 547.

16. Bollea-Garlatti ML, Bollea-Garlatti LA, Vacas AS, et al. Clinical characteristics and outcomes in a population with disseminated herpes zoster: A retrospective cohort study. Actas Dermosifiliogr 2017; 108: 145-52.

17. Karp SJ. Meningitis and disseminated cutaneous zoster complicating herpes zoster infection. J Neurol Neurosurq Psychiatry 1983; 46: 582-3.

18. Nigam P, Dayal SG, Dubey AL. Disseminated zoster. J Dermatol 1980; 7: 443-7.

Downloads

Published

2017-09-01

How to Cite

Kamolratanakul, S., & Dhitavat, J. (2017). Disseminated Herpes Zoster in immunocompetent host: A rare case report and review of the literature. Thai Journal of Dermatology, 33(3), 215–222. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/159071